Aviva’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$208M Buy
2,443,822
+244,758
+11% +$21.8M 0.35% 51
2025
Q4
$174M Sell
2,199,064
-60,056
-3% -$4.71M 0.29% 62
2025
Q3
$181M Buy
2,259,120
+310,248
+16% +$26.5M 0.33% 50
2025
Q2
$177M Buy
1,948,872
+925,802
+90% +$84.5M 0.37% 43
2025
Q1
$95.9M Buy
1,023,070
+49,649
+5% +$4.45M 0.23% 95
2024
Q4
$88.5M Buy
973,421
+114,855
+13% +$11M 0.23% 91
2024
Q3
$89.1M Buy
858,566
+53,490
+7% +$5.45M 0.23% 88
2024
Q2
$78.1M Buy
805,076
+88,997
+12% +$8.21M 0.22% 90
2024
Q1
$64.5M Buy
716,079
+326,894
+84% +$27.7M 0.21% 94
2023
Q4
$31M Buy
389,185
+137,323
+55% +$10.3M 0.11% 215
2023
Q3
$17.9M Sell
251,862
-214,519
-46% -$16M 0.08% 338
2023
Q2
$35.9M Sell
466,381
-28,735
-6% -$2.22M 0.15% 147
2023
Q1
$37.2M Buy
495,116
+19,627
+4% +$1.46M 0.17% 147
2022
Q4
$37.5M Buy
475,489
+102,634
+28% +$7.69M 0.18% 123
2022
Q3
$26.2M Sell
372,855
-69,028
-16% -$5.41M 0.15% 162
2022
Q2
$35.4M Buy
441,883
+87,629
+25% +$6.85M 0.19% 106
2022
Q1
$26.9M Buy
354,254
+71,410
+25% +$5.66M 0.13% 168
2021
Q4
$24.1M Sell
282,844
-26,507
-9% -$2.07M 0.1% 194
2021
Q3
$23.4M Sell
309,351
-18,342
-6% -$1.46M 0.1% 198
2021
Q2
$26.7M Buy
327,693
+45,031
+16% +$3.68M 0.12% 185
2021
Q1
$22.3M Sell
282,662
-2,367
-0.8% -$186K 0.11% 185
2020
Q4
$24.4M Buy
285,029
+12,852
+5% +$1.06M 0.13% 161
2020
Q3
$21M Sell
272,177
-8,834
-3% -$674K 0.12% 150
2020
Q2
$20.6M Sell
281,011
-24,692
-8% -$1.75M 0.13% 138
2020
Q1
$20.3M Buy
305,703
+122
+0% +$8.6K 0.15% 126
2019
Q4
$21M Sell
305,581
-1,608
-0.5% -$110K 0.13% 149
2019
Q3
$22.6M Sell
307,189
-15,792
-5% -$1.15M 0.15% 136
2019
Q2
$23.1M Sell
322,981
-9,543
-3% -$677K 0.16% 133
2019
Q1
$22.8M Buy
332,524
+342
+0.1% +$22.1K 0.15% 142
2018
Q4
$19.8M Sell
332,182
-92,686
-22% -$5.8M 0.15% 148
2018
Q3
$28.4M Sell
424,868
-16,663
-4% -$1.11M 0.16% 142
2018
Q2
$28.6M Sell
441,531
-6,600
-1% -$432K 0.17% 137
2018
Q1
$32.1M Sell
448,131
-93,670
-17% -$6.74M 0.2% 117
2017
Q4
$40.9M Sell
541,801
-66,288
-11% -$4.84M 0.23% 107
2017
Q3
$44.3M Buy
608,089
+7,493
+1% +$540K 0.24% 103
2017
Q2
$44.5M Sell
600,596
-463,320
-44% -$34.4M 0.25% 99
2017
Q1
$77.9M Buy
1,063,916
+183,384
+21% +$12.8M 0.45% 47
2016
Q4
$57.6M Sell
880,532
-15,410
-2% -$1.06M 0.34% 65
2016
Q3
$66.4M Buy
895,942
+13,430
+2% +$993K 0.41% 52
2016
Q2
$64.6M Buy
882,512
+350,802
+66% +$25M 0.44% 51
2016
Q1
$37.6M Buy
531,710
+7,069
+1% +$470K 0.28% 79
2015
Q4
$35M Sell
524,641
-7,383
-1% -$491K 0.27% 85
2015
Q3
$33.8M Sell
532,024
-11,705
-2% -$765K 0.28% 85
2015
Q2
$35.6M Buy
543,729
+23,600
+5% +$1.6M 0.25% 94
2015
Q1
$36.1M Buy
520,129
+118,700
+30% +$8.2M 0.25% 91
2014
Q4
$27.8M Buy
401,429
+14,430
+4% +$975K 0.22% 107
2014
Q3
$25.2M Sell
386,999
-4,830
-1% -$319K 0.2% 116
2014
Q2
$26.7M Buy
391,829
+3,000
+0.8% +$201K 0.2% 113
2014
Q1
$25.2M Buy
388,829
+14,730
+4% +$928K 0.2% 120
2013
Q4
$24.4M Buy
374,099
+114,038
+44% +$7.3M 0.2% 118
2013
Q3
$15.4M Buy
260,061
+78,001
+43% +$4.62M 0.14% 190
2013
Q2
$10.4M Buy
+182,060
New +$10.8M 0.11% 224

Other funds holding CL

Aviva's CL Position: Q1 2026 in Review

Aviva increased its Colgate-Palmolive (CL) stake by 11% in Q1 2026, buying an estimated $21.8M and bringing the position to 2,443,822 shares worth $208M. The position accounts for 0.35% of the portfolio, ranked #51.

Aviva first reported a position in CL in Q2 2013 and has held it in 52 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Aviva held 2,443,822 shares of Colgate-Palmolive worth $208M as of Q1 2026.
  • Aviva bought 244,758 Colgate-Palmolive shares in Q1 2026, an estimated $21.8M.
  • Colgate-Palmolive made up 0.35% of Aviva's portfolio in Q1 2026, its #51 holding.
  • Aviva first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Aviva's 13F filing for Q1 2026, filed 14 May 2026.